![]() |
Diego Alvarado Postdoctoral Fellow dalvarad@mail.med.upenn.edu |
I aim to obtain a quantitative and mechanistic understanding of the Drosophila EGF receptor (DER) system through biophysical and biochemical approaches. Together with a wealth of existing genetic information, these studies should generate a more complete picture of how the DER signaling complex functions in development and disease. In particular, I am attempting to establish the binding affinities of all four DER ligands for the receptor, and determine how different DER domains contribute to ligand binding and dimerization. In addition I will continue lab efforts to examine how the secreted antagonist Argos modulates DER signaling, possibly by sequestering multiple ligands and through interactions with heparan sulfate proteoglycans. |
![]() |
Kelley A. Bethoney Graduate Student kbethone@mail.med.upenn.edu |
I am interested in understanding the function of members of the large dynamin GTPase family, specifically dynamin, in membrane trafficking. Utilizing both cellular and biophysical approaches, I hope to better understand dynamin’s mechanism for participation in vesicle scission in clathrin-mediated endocytosis, specifically looking at the role of dynamin’s pleckstrin homology (PH) domain in this process. In addition, I am also pursuing crystallographic studies on members of the dynamin family to better understand the structural basis of dynamin function within the trafficking pathways. |
![]() |
Sung Hee Choi Graduate Student sunghee@mail.med.upenn.edu |
From recent clinical studies, several somatic mutations in the tyrosine kinase domain in EGFR were isolated from chemotherapy-reflecting, gefinitib-sensitive Non-Small Cell Lung Carcinomas (NSCLC) patients. I am interested in understanding how these mutations alter the function and regulation of the EGFR tyrosine kinase, as well as the cellular consequences of EGFR signaling. |
![]() |
Jessica P. Dawson, Ph.D. Postdoctoral Fellow dawsonj@mail.med.upenn.edu |
I
am currently examining the
energetic contribution of distinct regions of EGFR to receptor
dimerization and ligand binding. A series of mutations were designed at
specific contact points determined from the crystal structures and I am
testing each mutant protein for dimerization (analytical
ultracentrifugation), ligand binding (Biacore) and cellular signaling in vivo. |
![]() |
David Keleti Graduate Student dkeleti@mail.med.upenn.edu |
An
important component of
signaling pathways is the recruitment of key proteins from the cytosol
to a
specific subcellular membrane where they can exert their function. This
process
is driven by small, phosphoinositide-binding modules within the “host”
protein
called the pleckstrin homology (PH) domains. Recent biochemical and
biophysical
analyses performed in our lab suggest that PH domains may fall into one
of
three functional categories based on their phosphoinositide binding:
(1) a high
affinity, high specificity class; (2) a high
affinity, reduced specificity class ; (3) a low affinity, promiscuous
class in which lipid
binding is probably too weak to account for an in vivo
response. I propose
to study the latter two classes of PH domain using the following
approaches:
examine the
regiospecificity of PH
domain binding to lipids, examine phosphoinositide binding to 66
representative
human PH domains, find interacting protein partners of representative
human PH
domains. |
![]() |
Daryl E. Klein Graduate Student, MD/Ph.D. dek@mail.med.upenn.edu Personal web page |
The EGF receptor and its cognate ligands are found overexpressed or over-activated in many cancers. Highly selective antagonists of the EGFR, erbB2, and other erbB receptors, are extremely desirable for the treatment of a variety of cancers. My research is focused on two natural inhibitors of the EGF receptor axis found in Drosophila melanogaster. One (Argos) is a secreted protein with an EGF like module and resembles a growth factor, the other (Kekkon) is a leucine rich repeat (LRR) containing transmembrane protein. My research proposal focuses on obtaining a detailed mechanistic and structural understanding of how Argos and Kekkon function to antagonize dEGFR activation. |
![]() |
Mark A. Lemmon, Ph.D. Associate Professor mlemmon@mail.med.upenn.edu |
For a description of the lab's research click here. |
![]() |
Jeannine M. Mendrola, Ph.D. Postdoctoral Fellow mendrola@yahoo.com |
My current
focus in the lab
is to develop a protein complementation assay to assess homo- and
hetero-dimerization of erbB receptors in a cellular context.
Systems utilizing EYFP and mDHFR are under
development and the preliminary results are encouraging. In
concert with the biophysical/structural
studies ongoing in the laboratory, we hope to parse out the discrete
regions of
these receptors that make specific contacts in receptor dimers induced
by
exposure to erbB ligands. |
![]() |
Kartik Narayan Ph.D. Postdoctoral Fellow kartik@mail.med.upenn.edu |
I am investigating proteins and domains that might preferentially bind phosphatidylinositols-3,5-P2 using binding and crystallographic methods. |
| Mark Baumeister |
New York University,
Postdoctoral Fellow |
| Mitchell B. Berger |
UPenn, MD/Ph.D. Program |
| Kate Ferguson | University of Pennsylvania,
Assistant Professor |
| Jennifer M. Kavran |
Yale University, Ph.D. Program |
| Meghan King |
Rockefeller University,
Postdoctoral Fellow |
| Anthony Lee |
UCLA, Postdoctoral Fellow |
| Valerie Nappi |
VivaScience, New York |
| Mira M. Sachdeva |
University of Pennsylvania,
MD/Ph.D. Program |
| Vijay G. Sankaran |
Harvard Medical School, MD/Ph.D.
Program |
| Jong Yu |
Princenton University,
Postdoctoral Fellow |
| Lab Mailing Address: Department of Biochemistry and Biophysics, University of Pennsylvania, School of Medicine 242 Anatomy-Chemistry Building, Philadelphia, PA 19104-6059 Fax: (215) 573-4764 |
Lab
Address: Department of Biochemistry and Biophysics, University of Pennsylvania, School of Medicine 807 Stellar-Chance Building, 422 Curie Blvd, Philadelphia, PA 19104-6059 |